{"cik":"0001860663","entityName":"Monterey Bio Acquisition Corporation","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-11-12","val":14375000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}}},"us-gaap":{"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":24712,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":24712,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts":{"label":"Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs","description":"Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.","units":{"USD":[{"start":"2020-01-01","end":"2020-12-31","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020"},{"start":"2021-01-01","end":"2021-09-30","val":461667,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":375000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":468510,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":6843,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":6756,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2020-07-22","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q2I"},{"end":"2020-09-30","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3I"},{"end":"2020-12-31","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":6756,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-18244,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"CashEquivalentsAtCarryingValue":{"label":"Cash Equivalents, at Carrying Value","description":"Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CashFDICInsuredAmount":{"label":"Cash, FDIC Insured Amount","description":"The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.","units":{"USD":[{"end":"2021-09-30","val":250000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.0001,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":100000000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":100000000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2875000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2875000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":288,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":288,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"DeferredCosts":{"label":"Deferred Costs, Noncurrent","description":"Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.","units":{"USD":[{"end":"2021-09-30","val":461667,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"EarningsPerShareBasic":{"label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2020-07-23","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"EarningsPerShareDiluted":{"label":"Earnings Per Share, Diluted","description":"The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-07-23","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"IncreaseDecreaseInAccruedLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities","description":"The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-87,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":468510,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":1000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":444717,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-17950,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-294,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":-25,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-207,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":-182,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"NotesPayableRelatedPartiesClassifiedCurrent":{"label":"Notes Payable, Related Parties, Current","description":"The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":175405,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"OperatingCostsAndExpenses":{"label":"Operating Costs and Expenses","description":"Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":207,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":182,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"PaymentsOfStockIssuanceCosts":{"label":"Payments of Stock Issuance Costs","description":"The cash outflow for cost incurred directly with the issuance of an equity security.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":193355,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"PreferredStockParOrStatedValuePerShare":{"label":"Preferred Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.","units":{"USD/shares":[{"end":"2020-12-31","val":0.0001,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.0001,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"PreferredStockSharesAuthorized":{"label":"Preferred Stock, Shares Authorized","description":"The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2020-12-31","val":1000000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1000000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"PreferredStockSharesIssued":{"label":"Preferred Stock, Shares Issued","description":"Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"PreferredStockSharesOutstanding":{"label":"Preferred Stock, Shares Outstanding","description":"Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.","units":{"shares":[{"end":"2020-12-31","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"PrepaidExpenseAndOtherAssetsCurrent":{"label":"Prepaid Expense and Other Assets, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2021-09-30","val":87,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"ProceedsFromIssuanceOfCommonStock":{"label":"Proceeds from Issuance of Common Stock","description":"The cash inflow from the additional capital contribution to the entity.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"ProceedsFromRelatedPartyDebt":{"label":"Proceeds from Related Party Debt","description":"The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":175405,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"ProfitLoss":{"label":"Net Income (Loss), Including Portion Attributable to Noncontrolling Interest","description":"The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-207,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-1000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":-1207,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"SharesIssuedPricePerShare":{"label":"Shares Issued, Price Per Share","description":"Per share or per unit amount of equity securities issued.","units":{"USD/shares":[{"end":"2021-10-05","val":10.1,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2020-09-30","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3I"},{"end":"2020-12-31","val":24000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-03-31","val":24000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q1I"},{"end":"2021-06-30","val":23975,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q2I"},{"end":"2021-09-30","val":23793,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"StockIssuedDuringPeriodValueNewIssues":{"label":"Stock Issued During Period, Value, New Issues","description":"Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.","units":{"USD":[{"start":"2020-07-23","end":"2020-09-30","val":25000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"}]}},"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued":{"label":"Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued","description":"Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.","units":{"USD":[{"end":"2020-12-31","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3I"}]}},"WeightedAverageNumberOfDilutedSharesOutstanding":{"label":"Weighted Average Number of Shares Outstanding, Diluted","description":"The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.","units":{"shares":[{"start":"2020-07-23","end":"2020-09-30","val":2500000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":2500000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":2500000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}},"WeightedAverageNumberOfSharesOutstandingBasic":{"label":"Weighted Average Number of Shares Outstanding, Basic","description":"Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.","units":{"shares":[{"start":"2020-07-23","end":"2020-09-30","val":2500000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":2500000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12"},{"start":"2021-07-01","end":"2021-09-30","val":2500000,"accn":"0001410578-21-000164","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-12","frame":"CY2021Q3"}]}}}}}